University of Cambridge > Talks.cam > Entrepreneurship Centre at Cambridge Judge Business School > Judge Business School Health and Biotech Special Interest Group Dinner

Judge Business School Health and Biotech Special Interest Group Dinner

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Katharine Price.

We are delighted to welcome Sunil Shah as our speaker at the forthcoming Health and Biotech Special Interest Group dinner on 23rd March at Hughes Hall. Sunil will talk us through his entrepreneurial journey and provide some fascinating insights into what it takes to succeed in the highly competitive biotech sector.

• Drinks reception at 7pm 3-course dinner

• After dinner speaker – Sunil Shah (MBA 1998), Biotech entrepreneur

• After dinner drinks

Ticket price £30 (max number of guests 24). On line booking at http://www.cr.jbs.cam.ac.uk/events/event_details.asp?id=140039

It’s going to be a great evening with an inspiring speaker and an opportunity to meet and chat with a diverse group from the biotech and health sectors. We look forward to seeing you there.

Enquiries and further details on making payment for tickets: shelley.gregory-jones@phgfoundation.org / j.dean@jbs.cam.ac.uk /

After dinner speaker: Sunil Shah – Biotech Entrepreneur

Sunil studied biochemistry and management sciences at Keele and in 1998 followed it up with a MBA at the Judge. He started his career with PA Consulting but quickly moved into more entrepreneurial territory.

His first venture – as founder of Gosurprise Ltd – launched 4 internet brands including surpriseyourwoman.com. He successfully raised private and institutional money with investors including Channel 5 and is still a non-executive director.

In 2003 he launched the highly successful O2h which emerged from the Science Park in Cambridge and developed a talented team of scientists to provide a world class discovery service from its state-of-the-art research centre in India. The O2h delivery model has a proven track record of providing a step change in the effectiveness of drug discovery for a range of global pharmaceuticals and biotechnology companies operating at the forefront of early stage discovery programs.

O2h has just become a part of the Piramal Group. Business Weekly recently featured Sunil and described the acquisition as ‘a fabulous endorsement’ for O2h. Piramal – headquartered in Mumbai and quoted on the Indian Stock Exchange – has multi-billion dollar turnover and is a global top 10 Contract Research Organisation.

This talk is part of the Entrepreneurship Centre at Cambridge Judge Business School series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2019 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity